share_log

Biofrontera Has Received A Notice Of Allowance For Its U.S. Patent Application 17/269,816 Titled "Photodynamic Therapy Comprising Two Light Exposures At Different Wavelengths (For The Prevention Or Treatment Of Dermatological Disease)"

Benzinga Real-time News ·  Dec 23, 2022 11:27
Biofrontera Has Received A Notice Of Allowance For Its U.S. Patent Application 17/269,816 Titled "Photodynamic Therapy Comprising Two Light Exposures At Different Wavelengths (For The Prevention Or Treatment Of Dermatological Disease)"
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment